Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

32.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 56.40
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 261,268
  • Market Cap: £175.63m
  • RiskGrade: 119
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-23 182.43 40.18 4.54p 7.4 1.2 +6% 1.08p 0.0%
31-Dec-24 195.03 38.98 4.46p 7.5 n/a -2% 0.94p 0.0%
31-Dec-25 207.18 40.04 5.13p 6.5 0.4 +15% 0.98p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2024 195 195 n/a n/a n/a n/a
31-Dec-2025 207 207 n/a n/a n/a n/a
 
Earnings
31-Dec-2024 4.46p 4.46p n/a n/a n/a n/a
31-Dec-2025 5.13p 5.13p n/a n/a n/a n/a
 
Dividend
31-Dec-2024 0.94p 0.94p n/a n/a n/a n/a
31-Dec-2025 0.98p 0.98p n/a n/a n/a n/a
 
Recommendations
Strong Buy 4 4 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 3 3 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 7 7 0 0 0 0
 
Average Rec 7.86 7.86 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 32.50p
Change Today -1.00p
% Change -2.99 %
52 Week High 56.40
52 Week Low 29.35
Volume 261,268
Shares Issued 540.40m
Market Cap £175.63m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average94.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average74.91% below the market average
16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average16.98% below the sector average
Income
35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average35.94% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average89.14% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 17-Jun-2024

Time Volume / Share Price
11:16 30,863 @ 32.42p
11:10 3,000 @ 32.35p
11:09 5,260 @ 32.50p
11:03 20,108 @ 32.53p
11:01 38 @ 32.66p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page